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Graft revascularization is essential 
for non-invasive monitoring 
of transplanted islets with 
radiolabeled exendin
Wael A. Eter, Desirée Bos, Cathelijne Frielink, Otto C. Boerman, Maarten Brom & 
Martin Gotthardt
Islet transplantation is a novel promising strategy to cure type 1 diabetes. However, the long-
term outcome is still poor, because both function and survival of the transplant decline over-
time. Non-invasive imaging methods have the potential to enable monitoring of islet survival 
after transplantation and the effects of immunosuppressive drugs on transplantation outcome. 
111In-labeled exendin-3 is a promising tracer to visualize native and transplanted islets by SPECT 
(Single Photon Emission Computed Tomography). In the present study, we hypothesized that 
islet microvasculature plays an important role determining the uptake of exendin-3 in islets when 
monitoring transplant survival. We observed 111In-exendin-3 accumulation in the transplant as 
early as three days after transplantation and an increase in the uptake up to three weeks post-
transplantation. Islet-revascularization correlated with the increase in 111In-exendin-3 uptake, 
whereas fully re-established islet vasculature coincided with a stabilized uptake of the radiotracer 
in the transplant. Here, we demonstrate the importance of islet vasculature for in vivo delivery of 
radiotracers to transplanted islets and we demonstrate that optimal and stable uptake of exendin 
four weeks after transplantation opens the possibility for long-term monitoring of islet survival by 
SPECT imaging.
Reversal of type 1 diabetes by transplanting pancreatic islets has emerged as a promising therapeutic 
approach1,2. However, insulin independence shows a rapid decrease and can hardly be preserved beyond 
5 years after the intervention3. Moreover, several studies reported impaired islet survival after liver trans-
plantation, which was caused by insufficient revascularization4 and triggering of blood-mediated inflam-
matory reactions5, along with lipo and/or gluco-toxicity6,7.
Current functional tests cannot determine whether graft failure is caused by functional impairment 
of β -cells or β -cell loss, as many factors can be involved in this process (i.e. immune rejection, decline in 
islet function through metabolic or inflammatory stress)3,8. Biomedical imaging techniques can be used 
to monitor islet survival in addition to islet function measured by clinical testing and can therefore con-
tribute to future clinical decision making regarding treatment assignment or adaptation. Pre-labeling of 
islets with super-paramagnetic iron oxide particles (SPIOs) for MR imaging of islet transplants has been 
introduced a decade ago9. Further studies demonstrated that human islets transplanted in rodents can 
be monitored and quantified by MRI up to 6 months post-transplantation10. Labeling of the islets with 
SPIOs prior to transplantation is therefore a promising technique for clinical studies11.
In other studies, radioactive-based imaging methods were used for their advanced detection sensitiv-
ity of in vivo tracer uptake by transplanted or native islets12,13. In particular, SPECT imaging after injec-
tion of 111In-labeled exendin was reported as a promising strategy to non-invasively visualize engrafted 
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islets, as well as to visualize and quantify BCM in the pancreas of healthy and diabetic subjects14,15. 
Therefore, this tracer could be suitable for repeated longitudinal clinical imaging of islet transplants. The 
advantage of the tracer is the ability of repeated scanning without requiring pre-labeling of the islets 
prior to transplantation. However, the targeting properties of the radiotracer to the islet grafts early after 
transplantation may depend on the vasculature that is disrupted after islets isolation16–18.
Imaging of islet grafts in the skeletal muscle has been demonstrated previously15, and allows monitor-
ing of the transplant since the islets remain localized in a small engraftment area, where specific uptake 
can be easily discriminated from the surrounding tissue. Making use of this transplantation model, we 
determined the correlation between islet graft revascularization and the uptake of 111In-exendin-3 in the 
transplant for several weeks following islet transplantation.
Results
Radiolabeled exendin-3 binds to the GLP-1R on mouse islets in vitro. Incubation of 1.5 fmol of 
radiolabeled exendin-3 with 100 islets during 4 hours resulted in the binding of 9.1 × 10−3 fmol (Fig. 1). 
Binding of radiolabeled exendin-3 was reduced to 3.3 × 10−3 fmol in the presence of excess of unlabeled 
exendin-3 (p < 0.05). Binding of radiolabeled exendin-3 was two-fold higher when added to 300 islets 
(17.5 × 10−3 fmol) and binding was successfully decreased to 3.7 × 10−3 fmol by applying an excess of 
unlabeled exendin-3 (p < 0.001), which confirmed the expression of the GLP-1R.
Exendin-3 uptake in the skeletal muscle is localized in the transplanted islets. In order to 
determine whether the uptake of exendin-3 originates from the transplant within the skeletal muscle, 
we performed ex vivo autoradiography of the muscle regions that contained the islets, followed by his-
tochemical staining. As evidenced in Fig.  2(A–F), there was accumulation of 111In-exendin-3 within 
well-localized regions of the muscle after 3 days, 1, 2, 3, 4 and 6 weeks in the islet transplants. Sections were 
next analyzed by HE staining, where the uptake was confirmed as islet-specific. Immunohistochemical 
staining of muscle sections with an anti-insulin monoclonal antibody confirmed that the transplant pre-
dominantly consisted of β -cells (Fig. 2G). Quantitative analysis of 111In-exendin-3 accumulation within 
transplanted islets by autoradiography was 0.48 ± 0.068, 0.99 ± 0.16, 1.35 ± 1.08, 2.97 ± 0.27, 2.73 ± 0.4 
and 3.45 ± 0.34 Bq/mm2 at 3 days and 1, 2, 3, 4, 6 weeks after transplantation, respectively (Fig.  2H). 
Immunostaining of the GLP-1R with a polyclonal antibody confirmed the expression of the receptor in 
the transplants (Fig. 3).
The density of newly formed blood vessels in the transplant correlates with the uptake of 
exendin-3. To investigate whether revascularization of transplanted islets affects the uptake of radio-
labeled exendin-3, VEGFR-2 and insulin expression was quantified to determine islet microvasculature 
and β -cells area, respectively (Fig. 4). The first vascular structures in the graft were observed 3 days after 
transplantation. At that time, VEGFR-2 positive endothelial cells were mostly surrounding the transplant 
(Fig. 4A,B). There was notable progress of angiogenesis one week after transplantation, as more endothe-
lial cells had infiltrated the islets (Fig. 4C,D). Intra-islet vasculature was more prominent between 2 weeks 
and 6 weeks after transplantation, as vessels clearly had penetrated from the periphery into the core of 
the transplant (Fig. 4E–L). Quantitative analysis of revascularization showed notable progress between 3 
days and 3 weeks (p < 0.001) and a stablized vascular density between 3 and 6 weeks (Fig. 4M).
First signs of revascularization coincided with low exendin-3 uptake by 3-day old grafts and increase 
in islets vascular density correlated with the uptake of exendin-3 by the islets (Pearson correlation coef-
ficient r = 0.83) (Fig. 4N).
Figure 1. In vitro binding of radiolabeled exendin-3 to mouse pancreatic islets. Quantification of 
radiolabeled exendin-3 (black columns) shows higher binding to 300 islets than to 100 islets. Blocking of the 
receptor with an excess of unlabeled exendin-3 (white columns) significantly decreased the binding. Data 
are shown as means ± SEM from 3 experiments. *p < 0.05, ***p < 0.001 compared with the corresponding 
amount of islets, whereas ##p < 0.01 compared with 100 islets.
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In vivo visualization of islet transplants is dependent on islet revascularization. To assess the 
correlation between intra-islet vascular density and the tracer concentration in the transplant, SPECT 
scans were performed at different time-points after transplantation. SPECT visualized 3 day to 6 week-old 
transplants within the skeletal muscle (Fig.  5A). After 3 days, 12.5 ± 2.7 kBq/mm3 accumulated in the 
Figure 2. Ex vivo measurement of exendin-3 uptake by transplanted islets. (A–F) Autoradiography 
of muscle sections shows hotspots of In-111 accumulation. Histochemical staining of the corresponding 
autoradiography section shows co-localization between the uptake of exendin-3 and the transplant.  
(G) Adjacent sections were stained with anti-insulin mAb to confirm the presence of β -cells (brown). 
(H) Quantification of In-111 uptake (expressed in becquerel/mm2) according to autoradiography shows 
significant increase between 3 days to 3 week-old transplants (***p < 0.001) and stabilized uptake between 3 
and 6 weeks post-transplantation.
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transplants, which further increased up to 63 ± 4.7 kBq/mm3 at 4 weeks and remained similar up to 6 
weeks after transplantation (68 ± 3.2 and 67 ± 2.5 kBq/mm3, for week 5 and 6, respectively) (Fig.  5B). 
Ex vivo acquisitions were in line with the in vivo data, as signal could be detected after 3 days and was 
increased over time (Fig. 6). To determine the time-point after which multiple imaging sessions result in 
reproducible assessment of 111In-exendin-3 uptake, each mouse was scanned twice with 7 days of inter-
val, starting 3 days, 1, 2, 3, 4 or 5 weeks after transplantation (Fig.  7A). Quantitative analysis revealed 
an increase in the signal 7 days after the initial scans with stabilization being observed between 3 and 4 
week-old transplants (Fig.  7B). Increase in uptake was independent from the transplant size, since the 
uptake was normalized by the volume of the transplant. Two transplants which were not visible 3 days 
or 1 week after transplantation, both became detectable at the time of the second scan.
Discussion
In the present study, we examined the influence of islet graft revascularization on the targeting character-
istics of radiolabeled exendin-3, a radiotracer with great potential as imaging biomarker for non-invasive 
assessment of β -cell survival after transplantation. We demonstrated that an increase in vascular den-
sity, between 3 days and 3 weeks after transplantation, correlated with an increase in the accumulation 
of 111In-exendin-3 in the transplant. Furthermore, in mice in which no signal could be detected three 
days or one week after transplantation, islet grafts exhibited a detectable uptake at later time-points 
where vascularity improved. When the vascular bed had been established after 4 weeks, the uptake of 
exendin-3 indeed stabilized in repeated scans, indicating that islet revascularization has a direct influence 
on the targeting of transplanted islets after in vivo injection of radiotracers. Imaging of islet transplants 
Figure 3. GLP-1R expression is maintained in the islets early after transplantation. Representative images 
of 3 days (A–B), 2 weeks (C–D) and 4 week-old transplants (E–F) stained for GLP-1R (red) and insulin 
(green).
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with radiotracers will therefore reveal reproducible results starting 4 weeks after transplantation, the 
time-point after which the vascular bed of the transplants appears to have been established.
These findings indicate that recovery of islet vascular network is a prerequisite for reproducible lon-
gitudinal evaluation of viable islet grafts. First, complete restoration of islets vasculature improves the 
transplant signal-to-background ratio which facilitates the quantitative assessment of exendin-3 uptake. 
Secondly, reproducible uptake of exendin-3 is a requirement to accurately quantify BCM, and changes 
in the uptake after vasculature has recovered would most likely reflect β -cell loss.
Figure 4. Histological analysis of islets revascularization in the skeletal muscle. (A–L) Representative 
images of 3 days to 6 week-old islet transplants for which β -cells were stained with anti-insulin (green) and 
the ingrowing VEGFR2-expressing capillaries (red). All sections were counter-stained with DAPI (blue).  
(M) Quantification of vascular density within the insulin positive area shows significant increase in number 
of vessels from 3 days to 3 weeks (***p < 0.001). N: Initiation and increase of islets vascular density 
correlates with increasing exendin-3 uptake (pearson r = 0.83). Data are shown as means ± SEM from 4–5 
animals.
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Angiogenesis in recipients with long history of diabetes might be suboptimal19. Furthermore, graft 
angiogenesis rate is dependent on the transplantation site20. Therefore, the optimal time-point after 
which reproducible imaging results are obtained, might be affected by these parameters. The technique 
Figure 5. In vivo detection of pancreatic islets transplanted in the calf muscle. (A) Representative 
images of C3H mice with transplanted islets. Signal was detected 3 days, 1, 2, 3, 4, 5 and 6 weeks after 
transplantation (white arrows). (B) Quantitative analysis of the SPECT images showed a significant increase 
in the uptake of 111In-exendin-3 between 3 days and 3 weeks post-transplantation (***p < 0.001) and a 
stabilized uptake between 3 and 6 weeks. Data are presented as kBq/mm3 and are normalized by the injected 
dose.
Figure 6. Ex vivo detection of pancreatic islets transplanted in the calf muscle. Representative images 
from ex vivo scans of dissected muscles containing the transplant.
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will allow, however, to quantify islet survival, months, if not years after transplantation, where failure in 
maintaining normoglycemia could occur even after successful engraftment of the islets3.
It was previously reported that islets transplanted in liver can be visualized with small-animal PET, 
where the uptake of 64Cu-labeled exendin in the liver of transplanted animals was higher as compared to 
those of the control animals 12 days after transplantation12. Here we report the skeletal muscle as a suit-
able platform for characterization of tracer targeting properties to the islets. Using this model, we could 
investigate the role of the revascularization of the transplant on radiotracer uptake, since in this model 
the revascularization could be easily quantified ex vivo by histology. This transplantation site could be 
further used to characterize the targeting properties of novel β -cell radiotracers and to further evaluate 
existing ones with the advantage of fast histological evaluation of complete transplants.
In conclusion, this study revealed that islet revascularization is a key physiological process when 
monitoring islet transplants after in vivo targeting of the graft with β -cell tracers. Stable and reproduc-
ible uptake of exendin was achieved starting 4 weeks after transplantation, indicating that longitudinal 
assessment of islet survival by SPECT imaging can reproducibly be performed after this time point.
Research Design and Methods
Animals. Female C3H/HeNCrl mice (22–30 g) were purchased from Charles River (Calco, Italy). All 
experiments were conducted in accordance with Radboud University guidelines on humane care and use 
of laboratory animals, and were approved by the Animal Ethical Committee of the Radboud University, 
Nijmegen, The Netherlands.
Figure 7. In vivo detection of pancreatic islets at different weeks. (A) Representative images from in vivo 
scans at two different time-points with one week interval. Transplants are indicated with white arrows.  
(B) SPECT quantitative analysis where t2-t1 corresponds to 7 days interval between both scans shows 
improved uptake of 111In-exendin-3 and first signs of stabilization of tracer uptake between 3 weeks and 4 
weeks post-transplantation.
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Pancreatic islet isolation and transplantation. Pancreatic islets were isolated from 8 week-old 
female C3H/HeNCrl mice by collagenase digestion method. Mice were euthanized and 2 ml of cold 
RPMI 1640 (Invitrogen, Carmarillo, CA, USA) containing collagenase-V (0.9 mg/ml, Sigma Aldrich, 
St Louis, MO, USA) was infused via the pancreatic duct. Pancreata were collected in RPMI medium 
with collagenase and were digested at 37 °C for 12 min. The digested tissue was washed twice in RPMI 
medium and was filtered through a 500 μ m filter to separate the islets from undigested tissues. Islet 
purification was performed on a discontinuous Ficoll gradient (1.118, 1.096 and 1.037 g/ml, Cellgro by 
Mediatech Inc., Manassas, VA, USA), respectively, and centrifuged at 625 × g for 16 min without brake. 
Islets were collected from the aqueous phase between the first and second layer and washed twice with 
RPMI medium. Finally, islets were incubated overnight in a humidified 5% CO2 atmosphere at 37 °C in 
RPMI 1640 medium containing L-glutamine (Sigma), penicillin-streptomycin (10 mg/ml, Sigma Aldrich) 
and 10% v/v fetal calf serum (HyClone, Celbio, Logan, UT, USA). Islets were counted and hand-picked 
under a bright field microscope. Eight hundred islets were transferred to an eppendorf tube and cen-
trifuged at 62 × g for 2 minutes and aspirated in a canula by a Hamilton syringe. Syngenic transplanta-
tion was performed in the calf muscle, parallel to the fibula, using needles with a 0.8 mm diameter. To 
determine the exact number of transplanted islets, the canula was washed with fresh medium which 
was collected in the eppendorf tube used for preparation of the islets. The exact number of transplanted 
islets was determined by subtracting the remaining islets in the tube from the initially counted number.
Radiolabeling of exendin-3. [Lys40(DTPA)]-exendin-3 was purchased from Peptide Specialty 
Laboratories (Heidelberg, Germany). Peptide labeling with In-111 was performed as previously 
described14. Radiochemical purity was determined by ITLC and radiolabeled exendin-3 was purified 
by solid-phase extraction using a HLB-cartridge (Waters, Etten-Leur, The Netherlands) prior to animal 
injection as previously reported14. All animals were injected with 0.1 μ g of exendin-3 corresponding to 
approximately 15 MBq.
Binding assay on isolated islets. The binding of radiolabeled exendin-3 to islets was examined 
on isolated islets from C3H mice. After overnight recovery from isolation procedure, islets were col-
lected and the medium was removed by centrifugation as described above. The islets were diluted in 
binding buffer (RPMI 1640 containing 0.5% BSA (w/v)) and 100 or 300 islets (triplicate) were added 
to 24-transwell plates (Corning B.V. Life Sciences, Amsterdam, The Netherlands) and counted under a 
bright-field microscope (Meyer Instruments, Huston TX, USA). The islets were washed with 200 μ l of 
binding buffer and 1.5 fmol of In-111-exendin-3 in 200 μ l of binding buffer were added. Excess of unla-
beled exendin-3 (corresponding to 0.62 nmol) was added to 3 additional wells per condition to examine 
GLP-1R mediated binding. After 4 h incubation at 37 °C the islets were washed twice with binding buffer, 
the transwells containing the islets were measured in a γ -counter (Wallac 1480 Wizard, Perkin Elmer, 
Boston, MA, USA) and the bound fraction was determined.
Imaging procedure and data acquisition. Mice were injected intravenously with 15 MBq of 
exendin-3 and were scanned 1 hour after injection. Scans were performed with a small animal U-SPECT-II/
CT system (MILabs, Utrecht, The Netherlands) with a 1 mm multi-pinhole ultra-high sensitivity mouse 
collimator for 50 minutes. Mice were scanned after 3 days, 1, 2, 3, 4, 5 or 6 weeks post-transplantation. 
All mice were scanned twice with 7 days difference, under the same parameters. Immediately after the 
second SPECT acquisition, mice were euthanized and calf muscles containing the transplant were dis-
sected and were put in 4% paraformaldehyde inside eppendorf® tubes and were scanned ex vivo with 
the same settings. All images were reconstructed with OSEM (3 iterations, 16 subsets, voxel size 0.4 mm) 
using the U-SPECT-Rec software (MILabs, Utrecht, The Netherlands). CT scans were performed in full/
accurate mode or partial/fast mode under 615 μ A/s and 65 kV. For quantification of SPECT images, a 
volume of interest (VOI) was manually drawn around the observed uptake in the transplantation site and 
the background was subtracted by using the same VOI applied on the contra-lateral calf muscle, which 
contained no transplant. Data were corrected for the injected dose and converted to Bq by using external 
standards with known activity scanned and reconstructed with the same settings.
Histological analyzes. Muscles were fixed in 4% paraformaldehyde and embedded in paraffin after 
SPECT acquisition. For autoradiography, muscles were sliced into 4 μ m sections and were exposed to 
an imaging plate (Fuji Film BAS-SE 2025, Raytest, Straubenhardt, Germany) for 7 days. Images were 
visualized with a radioluminography laser imager (Fuji Film BAS 1800 II system, Raytest, Straubenhardt, 
Germany). Quantitative analysis of the autoradiographical images was performed using AIDA Image 
Analyzer software (Raytest GmbH, Straubenstadt, Germany). Data were acquired by drawing ROIs around 
each transplant as well as around the standards with known amount of radioactivity. Subsequently, sec-
tions were stained with hematoxylin-eosin (HE) to confirm the presence of pancreatic islets. Finally, for 
immunohistochemical staining of insulin, consecutive sections underwent antigen retrieval for 10 min in 
10 mM citrate pH 6 at 96 °C and blocked with 1% BSA in PBS for 30 minutes and endogenous peroxidase 
activity was blocked with 3% H2O2 in PBS for 30 minutes. Staining was performed using anti-insulin 
rabbit antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA) diluted 1/500 for 2 hours at room tem-
perature. Sections were incubated with swine anti-rabbit conjugated with peroxidase, for 1 hour at room 
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temperature and washed with PBS. The staining was developed with Bright DAB (Immunologic, Duiven, 
The Netherlands) and sections were visualized under bright-field microscopy. To normalize the autora-
diography measurements by the corresponding transplant surface, the outline of insulin-positive cells 
of consecutive sections was manually drawn in imageJ (data are expressed as Bq/mm2) . To normalize 
SPECT data by the size of the transplant, the volume was calculated by multiplying the insulin positive 
surface per level by the distance separating each analyzed section, that is 50 μ m. For determination of 
vascular density, consecutive sections were blocked with 1% BSA in PBS for 30 minutes and stained with 
anti-insulin guinea-pig antibody (Dako, Heverlee, Belgium) diluted 1/1000 and anti-VEGFR-2 rabbit 
antibody (Cell signaling, Danvers MA, USA) diluted 1/200 for 2 hours at room temperature. Sections 
were next incubated with goat anti-guinea pig Alexa 488 (1/200; Life technology, Dallas, TX, USA) and 
goat anti-rabbit Alexa 594 (1/200; Life technology), respectively, for 1 hour at room temperature. To 
confirm the expression of the GLP-1R, sections were blocked with 1% BSA in PBS for 30 minutes and 
stained with anti-GLP-1R rabbit antibody (Abcam, Cambridge, UK) diluted 1/500 for 2 hours at room 
temperature. Sections were next incubated with goat anti-rabbit Alexa 594 diluted 1/300 for 1 hour at 
room temperature. Sections were mounted and visualized with an epifluorescence microscope (Axioskop 
Zeiss, Thornwood, NY, USA).
Statistical analysis. Measurements are given as means ± SEM. Multiple comparisons were analyzed 
by one-way ANOVA and Bonferroni post-hoc test, P value < 0.05 was considered statistically significant. 
Data processing was performed with Graphpad Prism 5 (GraphPad Software, San Diego, CA, USA). 
Animals that showed no SPECT signal as well as no histological signs of insulin staining, were excluded 
from the study.
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